View More Recent Stories

Feb 3, 2021 07:30AM 9 Meters Biopharma, Inc. highlighted at upcoming Truist Securities' CEO Strategic Vision Conference Call Series
Feb 1, 2021 07:30AM 9 Meters Biopharma, Inc. Announces Research & Development Day on Short Bowel Syndrome
Dec 21, 2020 07:37AM 9 Meters Biopharma (NMTR) Announces Agreement with European Biomedical Research Institute of Salerno (EBRIS) to Continue Evaluation of Larazotide for COVID-19 Respiratory Complications
Dec 21, 2020 07:30AM 9 Meters Biopharma Announces Agreement with the European Biomedical Research Institute of Salerno (EBRIS) to Continue Evaluation of Larazotide for COVID-19 Respiratory Complications
Dec 15, 2020 04:00PM 9 Meters Biopharma, Inc. Announces Closing of Offering of Common Stock
Dec 11, 2020 08:35AM UPDATE: 9 Meters Biopharma (NMTR) Prices 46.154M Share Common Offering at $0.65/Sh
Dec 11, 2020 08:30AM 9 Meters Biopharma, Inc. Prices Public Offering of Common Stock
Dec 10, 2020 04:01PM 9 Meters Biopharma, Inc. Announces Proposed Public Offering of Common Stock
Dec 9, 2020 07:38AM 9 Meters Biopharma (NMTR) Receives Orphan Drug Designation for NM-003, Proprietary Long-Acting GLP-2, for Prevention of aGvHD
Dec 9, 2020 07:30AM 9 Meters Biopharma, Inc. Receives Orphan Drug Designation for NM-003, a Proprietary Long-Acting GLP-2, for Prevention of Acute Graft Versus Host Disease (aGvHD)
Dec 7, 2020 07:32AM 9 Meters Biopharma (NMTR) Announces Positive Topline Data for NM-002, a Proprietary Long-Acting GLP-1, in Phase 1b/2a Trial for Short Bowel Syndrome
Dec 7, 2020 07:30AM 9 Meters Biopharma, Inc. Announces Positive Topline Data for NM-002, a Proprietary Long-Acting GLP-1, in Phase 1b/2a Trial for Short Bowel Syndrome
Nov 16, 2020 07:35AM UPDATE: 9 Meters Biopharma (NMTR) Reports Positive Preclinical Data for NM-102
Nov 16, 2020 07:30AM 9 Meters Biopharma Announces Positive Preclinical Data for NM-102, a Gut Microbiome Modulator in an Immune Checkpoint Inhibitor Failure Model
Nov 2, 2020 08:00AM 9 Meters Biopharma, Inc. to Participate in the Following November Virtual Investor Conferences
Sep 8, 2020 08:30AM 9 Meters Biopharma, Inc. to Participate in September Investor Conferences
Aug 31, 2020 08:30AM 9 Meters Biopharma, Inc. Announces Formation of Scientific Advisory Board
Aug 13, 2020 04:30PM 9 Meters Biopharma, Inc. Highlighted at Upcoming Truist Securities' Catalyst Conference Call Series: "Prepping Ahead of Data"
Aug 12, 2020 04:30PM 9 Meters Biopharma, Inc. Provides Business Update and Announces Second Quarter 2020 Results
Aug 4, 2020 09:30AM 9 Meters Biopharma, Inc. to Participate in August Investor Conferences
Jul 28, 2020 07:30AM 9 Meters Biopharma, Inc. Announces Issuance of Patent for Use of Larazotide in Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)
Jul 21, 2020 07:45AM 9 Meters Biopharma, Inc. Doses the First Patients in Phase 1b/2a Clinical Trial in Short Bowel Syndrome
View More Recent Stories